An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A. Soucy, Steven Langston, James E. Brownell et al.|Nature|2009Cited by 2k
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Tary Traore et al.|Blood|2010Cited by 323
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer CellsJie Lin, Anindya Dutta, Michael A. Milhollen et al.|Cancer Research|2010Cited by 293